RecruitingNot ApplicableNCT05930483

Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

Using a SMART Design to Evaluate Remotely Delivered, Community-aligned Weight Loss Interventions Among Breast Cancer Survivors: The ¡Vida! Study


Sponsor

Fred Hutchinson Cancer Center

Enrollment

640 participants

Start Date

Apr 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates remotely delivered, community-aligned weight loss interventions in Latina breast cancer survivors. Breast cancer is the second leading cause of cancer death among women in the US. There are population differences in breast cancer mortality, based on specific risk factors, including obesity. Cancer is the leading cause of death among Latinos, and among Latinas, breast cancer is the leading cause of cancer death. An estimated 80% of Latinas in the United States have overweight/obesity, which is associated with poorer breast cancer outcomes. However, few, if any, effective interventions exist to promote and maintain weight loss in Latina breast cancer survivors. The development of an adaptive program that provides survivors with the support they need, as opposed to what is typically available, to improve breast cancer survivorship.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a remotely delivered weight loss program designed specifically for Hispanic/Latina breast cancer survivors, to improve health outcomes after cancer treatment. **You may be eligible if...** - You are a woman (biologically female), 18 or older - You self-identify as Hispanic or Latina - You can read and write in Spanish and/or English - You have a history of stage I–III breast cancer diagnosed within the past 5 years - You have no current evidence of cancer recurrence - It has been at least 60 days since your last cancer treatment (chemotherapy, radiation, or surgery) - Your BMI is 27 or higher - You have internet access and a phone **You may NOT be eligible if...** - Your BMI is below 27 - You use insulin or sulfonylurea drugs for diabetes (metformin is allowed) - You use GLP-1 weight loss medications (like Ozempic) - You are currently receiving cytotoxic chemotherapy - You are pregnant, breastfeeding, or planning pregnancy during the study - You are currently enrolled in another weight loss program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORAL¡Vida! program

Participate in ¡Vida! program

BEHAVIORAL¡Vida! Plus [¡Vida! + Experiential Learning (EL)]

Participate in ¡Vida! Plus program

BEHAVIORALHealth Coaching

Receive health coaching

BEHAVIORALMailed Toolkits

Receive a mailed toolkit of health items


Locations(1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05930483


Related Trials